ZimVie Valuation
Is ZIMV * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ZIMV * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ZIMV * (MX$230) is trading below our estimate of fair value (MX$1177)
Significantly Below Fair Value: ZIMV * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ZIMV *?
Other financial metrics that can be useful for relative valuation.
What is ZIMV *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$186.24m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.7x |
Enterprise Value/EBITDA | 8.4x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ZIMV *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.8x | ||
MEDICA B Médica Sur. de | 1.1x | 5.2% | Mex$4.4b |
BFLY Butterfly Network | 2.5x | 15.8% | US$162.1m |
A100120 Vieworks | 1.1x | 7.3% | ₩252.0b |
4163 INTAI Technology | 2.4x | n/a | NT$5.9b |
ZIMV * ZimVie | 0.2x | -1.6% | Mex$186.2m |
Price-To-Sales vs Peers: ZIMV * is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (5.4x).
Price to Earnings Ratio vs Industry
How does ZIMV *'s PE Ratio compare vs other companies in the Global Medical Equipment Industry?
Price-To-Sales vs Industry: ZIMV * is good value based on its Price-To-Sales Ratio (0.2x) compared to the Global Medical Equipment industry average (3.5x).
Price to Sales Ratio vs Fair Ratio
What is ZIMV *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.2x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate ZIMV *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.